Method to diagnose hereditary hemochromatosis
AssigneeMercator Genetics, Inc.
InventorsDennis T. Drayna, John N. Feder, Andreas Gnirke, Bruce E. Kimmel, Winston J. Thomas, Roger K. Wolff
Life of this patent
Estimating the term…
Abstract
New genetic markers for the presence of a mutation in the common hereditary hemochromatosis (HH) gene are disclosed. The multiplicity of markers permits definition of genotypes characteristic of carriers and homozygotes containing this mutation in their genomic DNA.
Claims13
A method to determine the likelihood of the presence or absence of common hereditary hemochromatosis (HH) in an individual comprising the steps of:
- (a) obtaining genomic DNA from said individual;
- (b) amplifying a HH-associated microsatellite marker with a primer pair selected from the group consisting of SEQ ID NOS. 31 and 32;
- SEQ ID NOS. 33 and 34;
- SEQ ID NOS. 35 and 36;
- SEQ ID NOS. 37 and 38;
- SEQ ID NOS. 39 and 40;
- SEQ ID NOS. 41 and 42;
- SEQ ID NOS. 43 and 44;
- SEQ ID NOS. 45 and 46;
- SEQ ID NOS.47 and 48;
- SEQ ID NOS. 49 and 50;
- SEQ ID NOS. 51 and 52;
- SEQ ID NOS. 53 and 54;
- SEQ ID NOS. 55 and 56;
- SEQ ID NOS. 57 and 58;
- SEQ ID NOS. 59 and 60;
- SEQ ID NOS. 61 and 62;
- SEQ ID NOS. 63 and 64;
- SEQ ID NOS. 65 and 66;
- SEQ ID NOS. 67 and 68;
- SEQ ID NOS. 69 and 70;
- SEQ ID NOS. 71 and 72;
- wherein said amplifying step further comprises the optional step of amplifying said DNA with a primer pair selected from the group consisting of SEQ ID NOS. 21 and 22;
- SEQ ID NOS. 23 and 24;
- SEQ ID NOS. 25 and 26;
- SEQ ID NOS. 27 and 28;
- and SEQ ID NOS. 29 and 30;
- and
- (c) determining the presence or absence of said microsatellite marker, wherein the presence of said microsatellite marker is indicative of the likely presence of HH in the individual and absence of said microsatellite marker is indicative of the likely absence of HH in the individual.
A method to determine the presence or absence of common hereditary hemochromatosis (HH) in an individual which comprises:
- (a) obtaining genomic DNA from said individual;
- (b) amplifying a HH-associated allele selected from the group consisting of :
- HHP-1, HHP-19G, and HHP-29G;
- and
- (c) determining the presence or absence of at least one HH-associated microsatellite marker in said individual using a primer pair selected from the group consisting of SEQ ID NOS. 31 and 32;
- SEQ ID NOS. 33 and 34;
- SEQ ID NOS. 35 and 36;
- SEQ ID NOS. 37 and 38;
- SEQ ID NOS. 39 and 40;
- SEQ ID NOS. 41 and 42;
- SEQ ID NOS. 43 and 44;
- SEQ ID NOS. 45 and 46;
- SEQ ID NOS. 47 and 48;
- SEQ ID NOS. 49 and 50;
- SEQ ID NOS. 51 and 52;
- SEQ ID NOS. 53 and 54;
- SEQ ID NOS. 55 and 56;
- SEQ ID NOS. 57 and 58;
- SEQ ID NOS. 59 and 60;
- SEQ ID NOS. 61 and 62;
- SEQ ID NOS. 63 and 64;
- SEQ ID NOS. 65 and 66;
- SEQ ID NOS. 67 and 68;
- SEQ ID NOS. 69 and 70;
- SEQ ID NOS. 71 and 72;
- wherein the presence of said HH-associated allele in combination with at least one microsatellite marker indicates the likely presence of HH in the individual and the absence of said HH-associated allele and said microsatellite marker indicates the likely absence of HH in the individual.
A pair of primers of about 18 nucleotides in length wherein said primers specifically amplify a common hereditary hemochromatosis (HH) associated marker selected from the group consisting of SEQ ID NO. 85;
- SEQ ID NO. 86;
- SEQ ID NO. 87;
- SEQ ID NO. 88;
- SEQ ID NO. 89;
- SEQ ID NO. 90;
- SEQ ID NO. 91;
- SEQ ID NO. 92;
- SEQ ID NO. 93;
- SEQ ID NO. 94;
- SEQ ID NO. 95;
- SEQ ID NO. 96;
- SEQ ID NO. 97;
- SEQ ID NO. 98;
- SEQ ID NO. 99;
- SEQ ID NO. 100;
- SEQ ID NO. 101;
- SEQ ID NO. 102;
- SEQ ID NO. 103;
- SEQ ID NO. 104;
- SEQ ID NO. 105;
- SEQ ID NO. 106;
- SEQ ID NO. 107;
- SEQ ID NO. 108;
- and SEQ ID NO. 109.
A DNA primer pair for amplification of a microsatellite marker associated with common hereditary hemochromatosis (HH) wherein the sequences of said primers are selected from the group consisting of SEQ ID NOS. 31 and 32;
- SEQ ID NOS. 33 and 34;
- SEQ ID NOS. 35 and 36;
- SEQ ID NOS. 37 and 38;
- SEQ ID NOS. 39 and 40;
- SEQ ID NOS. 41 and 42;
- SEQ ID NOS. 43 and 44;
- SEQ ID NOS. 45 and 46;
- SEQ ID NOS. 47 and 48;
- SEQ ID NOS. 49 and 50;
- SEQ ID NOS. 51 and 52;
- SEQ ID NOS. 53 and 54;
- SEQ ID NOS. 55 and 56;
- SEQ ID NOS. 57 and 58;
- SEQ ID NOS. 59 and 60;
- SEQ ID NOS. 61 and 62;
- SEQ ID NOS. 63 and 64;
- SEQ ID NOS. 65 and 66;
- SEQ ID NOS. 67 and 68;
- SEQ ID NOS. 69 and 70;
- and SEQ ID NOS. 71 and 72.
A kit for detection for the presence or absence of an hereditary hemochromatosis (HH)-associated microsatellite marker in an individual comprising:
- (a) at least one pair of primers of about 18 nucleotides in length, wherein said primer pairs specify amplify said (HH)-associated microsatellite marker selected from the group consisting of SEQ ID NO. 85;
- SEQ ID NO. 86;
- SEQ ID NO. 87;
- SEQ ID NO. 88;
- SEQ ID NO. 89;
- SEQ ID NO. 90;
- SEQ ID NO. 91;
- SEQ ID NO. 92;
- SEQ ID NO. 93;
- SEQ ID NO. 94;
- SEQ ID NO. 95;
- SEQ ID NO. 96;
- SEQ ID NO. 97;
- SEQ ID NO. 98;
- SEQ ID NO. 99;
- SEQ ID NO. 100;
- SEQ ID NO. 101;
- SEQ ID NO. 102;
- SEQ ID NO. 103;
- SEQ ID NO. 104;
- SEQ ID NO. 105;
- SEQ ID NO. 106;
- SEQ ID NO. 107;
- SEQ ID NO. 108;
- and SEQ ID NO. 109;
- and optionally,
- a primer pair selected from the group consisting of SEQ ID NOS. 31 and 32;
- SEQ ID NOS. 33 and 34;
- SEQ ID NOS. 35 and 36;
- SEQ ID NOS. 37 and 38;
- SEQ ID NOS. 39 and 40;
- SEQ ID NOS. 41 and 42;
- SEQ ID NOS. 43 and 44;
- SEQ ID NOS. 45 and 46;
- SEQ ID NOS. 47 and 48;
- SEQ ID NOS. 49 and 50;
- SEQ ID NOS. 51 and 52;
- SEQ ID NOS. 53 and 54;
- SEQ ID NOS. 55 and 56;
- SEQ ID NOS. 57 and 58;
- SEQ ID NOS. 59 and 60;
- SEQ ID NOS. 61 and 62;
- SEQ ID NOS. 63 and 64;
- SEQ ID NOS. 65 and 66;
- SEQ ID NOS. 67 and 68;
- SEQ ID NOS. 69 and 70;
- and SEQ ID NOS. 71 and 72.
Dependencies are inferred from the claim text.